Proteasome Inhibitors Market by Product and Geography - Global Forecast 2019-2023

July 2019 •
136 pages •
Report ID: 5796186 •
Format: PDF

Summary
Table of contents

Global Proteasome Inhibitors Market: About this market

Proteasome inhibitors are used for the treatment of multiple myeloma. This proteasome inhibitors market analysis considers sales from VELCADE, KYPROLIS, NINLARO, and other products segments. Our analysis also considers the sales of proteasome inhibitors in Asia, Europe, North America, and ROW. In 2018, the VELCADE segment held the highest market share, which is expected to remain prevalent over the forecast period. The drug is the first proteasome inhibitor to receive approvals from the FDA and EMA. Moreover, the drug is the most effective in treating multiple myeloma. These factors will significantly help the VELCADE segment in maintaining its leading market position. Also, our global proteasome inhibitors report has observed market growth factors such as the huge unmet need, strong adoption rate, and growing incidence of myeloma. However, the threat from biologics, strong adverse effects, and slow regulatory approval may hamper the growth of the proteasome inhibitors industry over the forecast period.

Global Proteasome Inhibitors Market: Overview

Huge unmet need

There is a significant unmet treatment need for myeloma and a few solid tumor indications. Vendors are leveraging this situation and are focusing on developing therapeutics for the same. The market also has only a few approved therapies. As a result, there is significant scope for vendors to expand into the market. Therefore, the huge unmet need and the rising incidence of cancer will propel the growth of the global proteasome inhibitors market over the forecast period. The market is expected to record a CAGR of about 8% during the forecast period.

Expanded application

Apart from treating myeloma and solid tumors, proteasome inhibitor drugs are also being used to cure non-oncology conditions. For instance, ACU-D1 is a novel proteasome inhibitor that is proven to treat rosacea. The drug is in its second phase of clinical studies. There is ongoing research on expanding applications of proteasome inhibitor drugs to treat other conditions. This factor will have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global proteasome inhibitors market is concentrated. This robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading proteasome inhibitors producers, which include Allergan Plc, Amgen Inc., Celgene Corp., Johnson & Johnson Services Inc., and Takeda Pharmaceutical Co. Ltd.

Also, the proteasome inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager